Loading
Life sciences · Review
Current Opinion in Endocrinology Diabetes and Obesity · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
PURPOSE OF REVIEW: The global prevalence of obesity continues to rise, with effects ranging across urology. This review summarizes recent evidence on obesity and its impact on various urological conditions, including malignancy, infections, stone disease, functional urology and male reproductive health, chronic kidney disease, and pediatric urology, to guide comprehensive management in this population. RECENT FINDINGS: Obesity has a paradoxical survival benefit in patients with renal cell carcinoma, while its impact drives aggressive prostate cancer. Obesity increases kidney stone risk, with sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists showing divergent effects on lithogenesis and urinary tract infections. It is a modifiable risk factor for overactive bladder and stress urinary incontinence, both of which improve with weight loss/ bariatric surgery. Robotic surgery mitigates obesity-related perioperative risk. Hypogonadism secondary to obesity is a major reversible cause of male infertility. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) reverse metabolic hypogonadism and helps in slowing chronic kidney progression. Maternal and childhood obesity may impair testicular descent and can also increase the risk of nocturnal enuresis. SUMMARY: Obesity's urological effects are heterogeneous, paradoxical from pediatric to adults, mediated by insulin resistance, chronic inflammation, and hormonal dysregulation. Weight loss and the use of GLP-1 RA may offer a unique strategy for optimizing and treating urological conditions.